1993
DOI: 10.1159/000139071
|View full text |Cite
|
Sign up to set email alerts
|

In vivo Evidence that Theophylline Is Metabolized Principally by CYP1A in Rats

Abstract: The role of various subfamilies of rat hepatic cytochrome P-450 in the oxidation of theophylline was evaluated by comparing theophylline clearance in control rats and those pretreated with relatively selective inducers and inhibitors of the cyto-chromes P-450. Pretreatment with the CYP1A inducer, β-naphthofiavone (BNF), increased theophylline clearance 4.5-fold (p < 0.001), and the CYP1A inhibitor, α-naphthoflavone, significantly attenuated the BNF effect. Pretreatment with phenobarbital, an inducer of CYP2B/C… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
9
1

Year Published

1995
1995
2017
2017

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 15 publications
(10 citation statements)
references
References 17 publications
0
9
1
Order By: Relevance
“…linear kinetics at the dosages used and minimum influence of protein binding on probe kinet ics. The utility of theophylline as a probe for CYP1A activity in rats has been reported [17]. Gu et al [18] reported that theophylline is principally oxidized by human CYP1A2.…”
Section: Discussionmentioning
confidence: 99%
“…linear kinetics at the dosages used and minimum influence of protein binding on probe kinet ics. The utility of theophylline as a probe for CYP1A activity in rats has been reported [17]. Gu et al [18] reported that theophylline is principally oxidized by human CYP1A2.…”
Section: Discussionmentioning
confidence: 99%
“…Twenty male Sprague-Dawley rats were randomly divided into four groups (n=5 rats each). During the morning of the experiment, PRN (5 mg/kg), IPRN (5 mg/kg), a-naphthoflavone (7 mg/kg) (positive control) (Bachmann et al, 1993), or vehicle was dosed intravenously for each group, respectively. The 5 mg/kg dose of PRN and IPRN was selected based on maximum doses in humans (60 mg/d, p.o.)…”
mentioning
confidence: 99%
“…To determine whether PCB 104-mediated activation of CYP1A1 and PARP mediates the observed endothelial cell dysfunction we pharmacologically inhibited CYP1A1 with α-naphthoflavone [28] and PARP with PJ-34 [29]. …”
Section: Resultsmentioning
confidence: 99%